The role of the oral cavity in SARS-CoV-2- and other viral infections
- PMID: 37310513
- PMCID: PMC10262116
- DOI: 10.1007/s00784-023-05078-z
The role of the oral cavity in SARS-CoV-2- and other viral infections
Abstract
Objective: This study aims to review the role of the oral cavity in SARS-CoV-2- and other viral upper respiratory tract infections.
Material and methods: Data reviewed in the text have been researched online and also reflect personal expertise.
Results: Numerous respiratory and other viruses replicate in the oral cavity and are transmitted via aerosols (< 5 µm) and droplets (> 5 µm). SARS-CoV-2 replication has been documented in the upper airways as well as in oral mucosa and salivary glands. These sites are also virus reservoirs that can infect other organs, e.g., the lungs and gastrointestinal tract, as well as other individuals. Laboratory diagnosis of viruses in the oral cavity and upper airways focuses on real-time PCR; antigen tests are less sensitive. For screening and monitoring infections, nasopharyngeal and oral swabs are tested; saliva is a good and more comfortable alternative. Physical means like social distancing or masks have been proven successful to reduce the risk of infection. Both wet-lab and clinical studies confirm that mouth rinses are effective against SARS-CoV-2 and other viruses. Antiviral mouth rinses can inactivate all viruses that replicate in the oral cavity.
Conclusions: The oral cavity plays an important role in viral infections of the upper respiratory tract: it serves as a portal of entry, a site of replication, and a source of infection by droplets and aerosols. Physical means but also antiviral mouth rinses can help reduce the spread of viruses and contribute to infection control.
Keywords: Aerosol; Droplets; Mouth rinse; Oral cavity; Replication; Virus.
© 2023. The Author(s).
Conflict of interest statement
Dieter Hoffmann received lecture and consultation honoraria from DENTAID SL (Cerdanyola, Spain).
Figures
Similar articles
-
Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2.J Dent Res. 2021 Feb;100(2):124-132. doi: 10.1177/0022034520967933. Epub 2020 Oct 22. J Dent Res. 2021. PMID: 33089717 Free PMC article. Review.
-
Is the oral cavity relevant in SARS-CoV-2 pandemic?Clin Oral Investig. 2020 Aug;24(8):2925-2930. doi: 10.1007/s00784-020-03413-2. Epub 2020 Jun 23. Clin Oral Investig. 2020. PMID: 32577830 Free PMC article.
-
Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles.Sci Rep. 2020 Dec 31;10(1):22430. doi: 10.1038/s41598-020-79985-6. Sci Rep. 2020. PMID: 33384436 Free PMC article.
-
Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro.J Dent Res. 2021 Oct;100(11):1265-1272. doi: 10.1177/00220345211029269. Epub 2021 Jul 20. J Dent Res. 2021. PMID: 34282982
-
Oral antiseptics against coronavirus: in-vitro and clinical evidence.J Hosp Infect. 2021 Jul;113:30-43. doi: 10.1016/j.jhin.2021.04.004. Epub 2021 Apr 15. J Hosp Infect. 2021. PMID: 33865974 Free PMC article. Review.
Cited by
-
SARS-CoV-2 natural infection, but not vaccine-induced immunity, elicits cross-reactive immunity to OC43.Heliyon. 2024 Sep 21;10(19):e37928. doi: 10.1016/j.heliyon.2024.e37928. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39391514 Free PMC article.
-
Oral and periodontal manifestation related during human papilloma virus infections: Update on early prognostic factors.Heliyon. 2024 May 14;10(10):e31061. doi: 10.1016/j.heliyon.2024.e31061. eCollection 2024 May 30. Heliyon. 2024. PMID: 38813162 Free PMC article. Review.
-
"What has dentistry learned from the pandemic?".Clin Oral Investig. 2023 Jun;27(Suppl 1):1-2. doi: 10.1007/s00784-023-05036-9. Clin Oral Investig. 2023. PMID: 37162569 Free PMC article. No abstract available.
-
Herpesviruses and SARS-CoV-2: Viral Association with Oral Inflammatory Diseases.Pathogens. 2024 Jan 7;13(1):58. doi: 10.3390/pathogens13010058. Pathogens. 2024. PMID: 38251365 Free PMC article. Review.
-
Effectiveness of Preprocedural Mouthwashes: A Triple-Blind Randomised Controlled Clinical Trial.Int Dent J. 2025 Apr;75(2):868-876. doi: 10.1016/j.identj.2024.08.017. Epub 2024 Oct 6. Int Dent J. 2025. PMID: 39370336 Free PMC article. Clinical Trial.
References
-
- van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382:1564–1567. doi: 10.1056/NEJMc2004973. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous